Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients
Mei Meng(Shanghai Jiao Tong University), Dechang Chen(Shanghai Jiao Tong University), Lidi Zhang(Shanghai Jiao Tong University), Yan Xu(Shanghai First People's Hospital), Xuan Dong(The Ohio State University), Jieming Qu(Shanghai Jiao Tong University), Djillali Annane(Université Paris-Saclay), Hangxiang Du(Shanghai Jiao Tong University), Yunxin Deng(Shanghai Jiao Tong University), Jiao Liu(Shanghai Jiao Tong University), Tao Wang(Shanghai Jiao Tong University), Limin Chen(Shanghai Jiao Tong University), Ranran Li(Shanghai Jiao Tong University), Sisi Huang(Shanghai Jiao Tong University), Sheng Zhang(Shanghai Jiao Tong University), Yizhu Chen(Shanghai Jiao Tong University), Wenzhe Li(Peking University), Yanxia Huang(Shanghai Jiao Tong University), Yongan Liu(Shanghai Jiao Tong University), Zhenliang Wen(Shanghai Jiao Tong University)
Cited by 21
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k